Lifecore Biomedical to be acquired by Webster Equity Partners (LFCR:NASDAQ)
· seekingalpha.com
Lifecore Biomedical (LFCR) to be acquired by Webster Equity for up to $663.7M, offering a 49.5%–130% premium and CVR.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...